HARRIGAN EDMUND - Insider Non-Derivative Transactions at PhaseBio Pharmaceuticals Inc (PHAS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 19, 2023, HARRIGAN EDMUND's relationship to PhaseBio Pharmaceuticals Inc (PHAS) is Director, and currently has 9,750 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PHAS insiders.
Data Source: SEC.
HARRIGAN EDMUND - Insider Non-Derivative Transactions at PHAS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 20, 2023 | M -- (Common Stock) | 3750 | 0 | 9750 |